Washington University & Rush University Med. Center In Pursuit of Reprogramming Pancreatic Cancer—Phase I Clinical Trials Coming Soon

Washington University & Rush University Med. Center In Pursuit of Reprogramming Pancreatic Cancer—Phase I Clinical Trials Coming Soon

Washington University School of Medicine, St. Louis and Rush University Medical Center, Chicago investigators have found that a type of white blood cell called tumor-associated macrophages that been deceived by pancreatic cancer cells into not attacking them can be...

Pin It on Pinterest